Publications by authors named "Jeremy D Jokinen"

Claim this Profile
E
Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance.
Inyoung Lee, Jeremy D Jokinen, Stephanie Y Crawford, Gregory S Calip, Ryan D Kilpatrick

Ther Innov Regul Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance.
Inyoung Lee, Todd A Lee, Stephanie Y Crawford, Ryan D Kilpatrick, Gregory S Calip, Jeremy D Jokinen

Expert Opin Drug Saf· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooling Different Safety Data Sources: Impact of Combining Solicited and Spontaneous Reports on Signal Detection In Pharmacovigilance.
Jeremy D Jokinen, Rosalind J Walley, Michael W Colopy, Thomas S Hilzinger, Peter Verdru

Drug Saf· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Alternative to Disproportionality: A Frequency-Based Method for Pharmacovigilance Data Mining.
Jeremy D Jokinen, Fabio Lievano, Linda Scarazzini, Melissa Truffa

Ther Innov Regul Sci· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on Pepino et al. Sucralose affects glycemic and hormonal responses to an oral glucose load. Diabetes care 2013;36:2530-2535.
V Lee Grotz, Jeremy D Jokinen

Diabetes Care· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of administration of dolasetron affects dose necessary to prevent postoperative nausea and vomiting.
Kari T Korttila, Jeremy D Jokinen

J Clin Anesth· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis